NCT00126373View on ClinicalTrials.gov

A Trial of Wellbutrin for Crohn's Disease

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Crohn Disease

Interventions

DRUG

Wellbutrin (bupropion)

bupropion 150mg-300mg daily

Trial Locations (2)

10029

Mt. Sinai Medical Center, New York

60637

University of Chicago, Chicago

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Altschuler, Eric, M.D.

INDIV